Health Vector and Primetime Medical Software Forge Partnership to Address the COVID-19 Pandemic

BOSTON, March 18, 2020 /PRNewswire/ — Health Vector and Primetime Medical Software announced an exclusive partnership that brings the leading strengths of each company to transform patient engagement through a new class of health management apps.

The revolutionary Health Vector app has a comprehensive Coronavirus screening module. Clinicians can remotely screen patient-reported symptoms and travel history for risk factors and triage suspected COVID-19 cases.

The landmark partnership aims to redefine the way users interact with clinicians and coaches, address key engagement challenges and spark true patient activation, grounded in four core capabilities:

  • Appropriate utilization of healthcare
  • Relevant patient-clinician communication
  • Effective behavioral change
  • Action analytics and insights

The Health Vector unified solution is a patient decision support system that meets users where they are and motivates appropriate utilization of healthcare services. It gives users the necessary tools to bring awareness of the factors influencing health and well-being, empowering with the skills, knowledge and confidence needed to take action, together with the healthcare provider, for collaborative and informed decisions. The e-Visit / appointments modules include high quality medical history documentation and treatment plan transcriptions with ICD-10 coding which can be transferred into all major EHRs.

Primetime Medical Software, which powers the e-Visit module, is an indispensable part of patient-clinician communication leading to reductions in physician burn-out. It saves clinicians 3 minutes per encounter and reduces EHR clicks by 28%. Automated clinical note documentation significantly improves coding accuracy resulting in increased revenues.

About Health Vector
Health Vector is an innovative health management solution that pioneers a new form of patient activation to significantly boost engagement and reduce wellness and medical costs using artificial intelligence insights, principles of cognitive behavioral therapy and action analytics. Health Vector was founded in 2017 and is headquartered in Newton, MA. https://www.healthvector.world/ or download on Apple Store or Google Play

About Primetime Medical Software
Since 1985, Primetime Medical Software, Inc. has been compiling medical knowledge bases for patient interviewing in electronic health records (Cerner, eClinicalWorks, GE Health, NexGen). Designed by physicians for use in the office and telehealth, the knowledge bases contain questionnaires for more than six thousand distinct patient complaints. http://www.medicalhistory.com.


 

View original content:http://www.prnewswire.com/news-releases/health-vector-and-primetime-medical-software-forge-partnership-to-address-the-covid-19-pandemic-301026012.html

SOURCE Health Vector

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

5 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

8 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

8 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

8 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

8 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

8 hours ago